Glocal Regulatory Expertise. Cultural Clarity. Unified Outcomes.
Bridging regulatory compliance with product innovation — globally, clearly, effectively.
We’ve Got a Vision
To contribute to a real impact on patients’ lives.
We help biotech and SMEs overcome regional barriers — unlocking Big Pharma-level expertise for everyone.
From market intelligence to entry strategy and building local teams, we’re with you for the entire journey — together.
What We Are:
-
Strategic navigators of regulatory complexity
-
Translators of global frameworks into actionable roadmaps
-
Accelerators of patient access through compliance expertise
What We Are Not:
-
Drug discoverers — we don’t create molecules, we clear the path for them
-
Research labs — our work starts where the lab work ends
-
Passive consultants — we’re active partners from strategy to execution
1
Global Regulatory Intelligence & Product Development Innovation
The Challenge We Face
2
We know the Latest Regulations, Market Trends, and Technological AI innovation
Because the future is Now
3
Embracing the AI Revolution in Medical Devices and Glocal Opportunities.
Why This Transformation Matters to Our Industry
Traditional regulatory approaches struggle to keep pace with New Technology and AI-driven medical innovations.
Success requires understanding both the technology being developed and the regulatory landscape it's disrupting. Moving fast is even more important and regional development can help accelerating.
You can learn every regulation by heart — but unless you understand the unwritten ones, you’ll still get stuck. Real progress comes through trust, nuance, and a feel for the local rhythm. Our network wasn’t built overnight — it came from shared deadlines, unfiltered conversations, and more coffee than we care to admit. That’s the real map. That’s where the value lives.
Camilla Costa
Director and Co-Founder, BSc, MSc
BC Regulatory Affairs Consulting
Camilla moves between worlds — science and policy, vision and precision — with the quiet confidence of someone who’s turned roadblocks into approvals more times than she can count. She brings deep respect for both regulators and innovators, a sharp instinct for clarity, and a steady belief that good regulation should open doors, not close them.
